• Monika Mittal Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, India.
  • Nomita Gupta Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, India.
  • Palak Parashar Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, India.
  • Varsha Mehra Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, India
  • Manisha Khatri Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, India


Medicinal plants are generating an ever-increasing amount of interest due to the effectiveness, low cost and minimal side-effects associated with drugs derived from them. Clove (Syzygium aromaticum (L.) (Family Myrtaceae) is one of the most important herbs in traditional medicine, having a wide spectrum of biological activity. Phytoconstituents of clove comprise of various classes and groups of chemical compounds such as monoterpenes, sesquiterpenes, phenolics and hydrocarbon compounds. The major phytochemicals found in clove oil is mainly eugenol (70-85%) followed by eugenyl acetate (15%) and β-caryophyllene (5–12%). Their derivatives result in biological benefits such as antibacterial, antifungal, insecticidal, antioxidant, anticarcinogenic capacities. In addition to clove oil’s worldwide use as a food flavoring agent, it has also been employed for centuries as a topical analgesic in dentistry. This review presents an overview and details of the phytochemical and pharmacological investigations on the S. aromaticum.


Keywords: Clove, Syzygium aromaticum, Phytoconstituents, Pharmacological activity.


Download data is not yet available.

Author Biographies

Varsha Mehra, Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, India

Assistant Professor, Department of Biomedical Science, 

Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, 

Manisha Khatri, Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, India

Assistant Professor, Department of Biomedical Science, 

Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, 


1. Prince A, Powell C. Clove oil as an anesthetic for invasive field procedures on adult rainbow trout. N Am J Fish Manage 2000;20:1029-32.
2. Srivastava SK, Nagpure NS, Kushwaha B, Ponniah AG. Efficacy of clove oil as an anaesthetic agent in fishes. Ind J Anim Sci 2003;73:466-7.
3. Kim HM, Lee EH, Hong SH, Song HJ, Shin MK, Kim SH, Shin TY. Effect of Syzygium aromaticum extract on immediate hypersensitivity in rat. J Ethnopharmacol 1998;60:125-31.
4. Zheng GQ, Kenny PM, Lam KT. Sesquiterpenes from clove (Eugenia carrophyllata) as potential anticarcinogenic agents. J Nat Prod 1992;55:999-1003.
5. Miyazawa M, Hisama M. Antimutagenic activity of phenylpropanoides from clove (Syzygium aromaticum). J Agric Food Chem 2003;51(22):6413-22.
6. Chaieb K, Zmantar T, Ksouri R, Hajlaoui H, Mahdouani K, Abdelly C, Bakhrouf A. Antioxidant properties of essential oil of Eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species. J Mycosis 2007b;50(5):403-6.
7. Hussein G, Miyashiro H, Nakamura N, Hattori M, Kakiuchi N, Shimotohno K. Inhibitory effects of Sudanese medical plant extracts on hepatitis C virus (HCV) protease. J Phytother Res 2000;14:510-6.
8. Srivastava KC, Malhotra N. Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets. J Prostaglandins Leukot Essent Fatty Acids 1991;42(1):73-81.
9. Yang YC, Lee SH, Lee WJ, Choi DH, Ahn YJ. Ovicidal and adulticidal effects of Eugenia cryophyllata bud and leaf oil compounds on Pediculus capitis. J Agric Food Chem 2003;51(17):4884-8.
10. Pino JA, Marbot R, Aguero J, Fuentes V. Essential oil from buds and leaves of clove (Syzygium aromaticum (L.) Merr. et Perry) grown in Cuba. J Essen Oil Res 2001;13(4):278-9.
11. Raina VK, Srivastava SK, Aggarwal KK, Syamasundar KV, Kumar S. Essential oil composition of Syzygium aromaticum leaf from Little Andaman, India. J Flavour Frag 2001;16(5):334-6.
12. Zachariah TJ, Krishnamoorthy B, Rema J, Mathew PA. Oil constituents in bud and pedicel of clove (Syzygium aromaticum). J Indian Perfumer 2005;49:313-6.
13. Gopalakrishnan M, Narayanan CS, Mathew AG. Sesquiterpene hydrocarbons from clove oil. J Lebensmittel-Wissenschaft Und-Technologie B 1984;17:42-3.
14. Kamatou GP, Vermaak I, Vilijoen A M. Eugenol-from the remote Maluku islands to the International market place:A review of a remarkable and versatile molecule. J Molecules 2012;17:6953-81.
15. Cai L, Wu CD. Compounds from Syzygium aromaticum Possessing Growth Inhibitory activity against Oral Pathogens. J Nat Prod 1996;59(10):987-90.
16. Ghelardini C, Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A. Local anaesthetic activity of beta-caryophyllene. J Farmaco 2001;56(5-7):387-9.
17. Soares DC, Portella NA, Ramos MF de S, Siani AC, Saraiva EM. Trans-β-Caryophyllene: An Effective Antileishmanial Compound Found in Commercial Copaiba Oil (Copaiferaspp.). J Evid based Complement Alternat Med 2013; 10.1155/ 2013/761323.
18. Bakır B, Him A, Ozbek H, Duz E, Tutuncu M. Investigation of the anti-inflammatory and analgesic activities of β-caryophyllene. Int J Essen Oil Ther 2008;2(1):41-4.
19. Calleja MA, Vieites JM, Montero-Meléndez T, Torres MI, Faus MJ, Suárez A. The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. Br J Nutr 2014; 109(3):394-401.
20. Fitzgerald DJ, Stratford M, Gasson MJ, Ueckert J, Bos A, Narbad A. Mode of antimicrobial action of vanillin against Escherichia coli, Lactobacillus plantarum and Listeria innocua. J Appl Microbiol 2004;97:104-13.
21. Tai A, Sawano T, Yazama F. Antioxidant Properties of Ethyl Vanillin in vitro and in vivo. J Biosci Biotechnol Biochem 2013;75:2346-50.
22. Shoeb A, Chowta M, Singh A. Evaluation of antidepressant activity of vanillin in mice. Indian J Pharmacol 2013;45(2):142-4.
23. Tena SS, Zurita FJR, Moralli SD, Vinardell MP, Reed M, García FG, et al. Maslinic Acid-Enriched Diet Decreases Intestinal Tumorigenesis in ApcMin/+Mice through Transcriptomic and Metabolomic Reprogramming. J PloS One 2013;doi:10.1371/journal.pone.0059392.
24. Tatsimo SJN, Dieu Tamokou JD, Havyarimana L, Csupor D, Forgo P, Hohmann J, et al. Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum. J BMC Res Notes 2012;5(1):158.
25. Kong L, Luo C, Li X, Zhou Y, He H. The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits. J Lipids Health Dis 2013;doi:10.1186/1476-511X-12-115.
26. Kim SH, Choi KC. Anticancer effect and underlying mechanism(s) of Kaempferol a phytoestrogen,on the regulaton of apoptosis in diverse cancer cell models. J Toxicol Res 2013;29(4):229-34.
27. Jnawali HN, Lee E, Jeong KW, Shin A, Heo YS, Kim Y. Anti-inflammatory Activity of Rhamnetin and a Model of Its Binding to c-Jun NH-Terminal Kinase 1 and p38 MAPK. J Nat Prod 2014;77(2):258-63.
28. Park ES, Kang JC, Jang YC, Park JS, Jang SY, Kim DE, et al. Cardio protective effects of rhamnetin in H9c2 cardio myoblast cells under Hâ‚‚Oâ‚‚-induced apoptosis. J Ethno pharma col 2014;153(3):552-60.
29. Fawe A, Zaid MA, Menzies JG, Bélanger RR. Silicon-Mediated Accumulation of flavonoid Phytoalexins in Cucumber. J Phytopathol 1998;88:396-401.
30. Andrioli WJ, Silva TM, Silva VB da, Damásio ARL, Maller A, Conti R, et al. The fungal metabolite eugenitin as additive for Aspergillus niveus glucoamylase activation. J Mol Catal B-Enzym 2012;74:156-61.
31. Borges A, Ferreira C, Saavedra MJ, Simoes M. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria. J Micro Drug Resist 2013;19(4):256-65.
32. Couto AG, Kassuya CAL, Calixto JB, Petrovick PR. Anti-inflammatory, antiallodynic effects and quantitative analysis of gallic acid in spray dried powders from Phyllanthus niruri leaves, stems, roots and whole plant. J Rrevista brasileira de farmacognosia 2013;23(1):124-31.
33. Bhuiyan MNI, Begum J, Nandi NC, Akter F. Constituents of the essential oil from leaves and buds of clove (Syzygium caryophyllatum (L.) Alston) Afr J Plant Sci 2010;4(11):451-4.
34. Vasconellos MC, Benzerra DP, Fonseca AM, Pessoa C, Lemos TL, Costa Lotufo LV, de moraes M O, Montenegro R C. The in vitro and in vivo inhibitory activity of biflorin in melanoma. J Melanoma Res 2011;21(2):106-14.
35. Hendra R, Ahmed S, oskoueian E. Flavanoid analysis and antimicrobial activity of various parts of phaleria macrocarpa (Sccheff.). Boerl Fruit Int J Sci 2011;12(6):3422-31.
36. Sun F, Zheng XY, Ye J, Wu TT, Wang JI Chen W. Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo. J Nutr cancer 2012;64(4):599-606.
37. Wang SJ, Tong Y, Yang R, Liao X, Xu YF, Li X. Anti-inflammatory activity of myricetin isolated from Myrica ruba sieb. et Zucc.leaves. J Planta Med 2010;76(14):1492-6.
38. Cai L, Wu CD. Compounds from Syzygium aromaticum Possessing Growth Inhibitory activity against Oral Pathogens. J Nat Prod 1996;59(10):987-90.
39. Kamurthy H, Ch S, Rao S. N, Sudhakar M. Antinocieptive Activity of stigmasterol-3-glyceryl-2-linoleiate, Campesterol and Daucosterol isolated from Aerva Lanata Linn. Aerial parts. Asian J Pharmaceut Clin Res 2013;6(1).
40. Choi J, Lee E, Lee H, Kim K, Ahn K, Shim B, et al. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities. J Phytother Res 2007;21(10):954-9.
41. Ghosh T, Maity TK, Singh J. Evaluation of antitumor activity of stigmasterol, a constituent isolated from Bacopa monnieri Linn aerial parts against Ehrlich Ascites Carcinoma in mice. J Orient Pharm Exp Med 2011;11(1):41-9.
42. Cheng J, Duan DD, Wang YN, Ma LQ, Liu YB, Shi GJ. Acaricidal Activity of Stigmasterol from Inula Britannica against Tetranychus cinnabarinus. J Adv Intel Soft Comput 2012;134:599-609.
43. Chen W, Hu YP, Bao J, Tang J, wWu L. Stigmasterol blocks cartilage degradation in rabbit model of osteoarthritis. J Acta Biochimica polonica 2012;59(4):537-41.
44. Castellano JM, Guinda A, Deloado T, Rada M, Cavuela J A. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. J Diabetes 2013;62(6):1791-9.
45. Horiuchi K, Shiota S, Hatano T, Yoshida T, Kuroda T, Tsuchiva T. Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE). J Biol Pharm Bull 2007;30(6):1147-9.
46. Feng JH, Chen W, Zhao Y, Ju XL. Antitumor activity of Oleanolic, Ursolic and Glycyrrhetinic acid. The Open Nat Prod J 2009;2:48-52.
47. Gupta N, Mittal M, Parashar P, Mehra V, Khatri M. Antibacterial Potential of Elletaria cardamomum, Syzygium aromaticum and Piper nigrum, their synergistic effects and phytochemical determination. J Pharm Res 2014;8(8).
48. Fu Y, Zu Y, Chen L, Shi X, Wang Z, Sun S, Efferth T. Antimicrobial activity of clove and rosemary essential oils alone and in combination. J Phytother Res 2007;21(10):989-94.
49. Cai L, Wu CD. Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens. J Nat Prod 1996;59(10):987-90.
50. Burst SA, Reinders RD. Antibacterial activity of selected plant essential oils against Escherichia coli O157:H7. J Lett Appl Microbiol 2003;36(3):162-7.
51. Demirpek U, Olgun A, Kısa O, Guvenç A. In vitro antibacterial activity of cloves (Syzygium aromaticum) against MRSA. J Planta Med 2009;75:PJ59.
52. Ali SM, Khan AA, Ahmed I, Musaddiq M, Ahmed KS, Polasa H. Antimicrobial activities of eugenol and cinnamaldehyde against the human gastric pathogen Helicobacter pylori. J Ann Clin Microbiol Antimicrob 2005;4:20.
53. Eugenia P, Luıs VS, Carlos C, Lıgia S. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol 2009;58:1454-62.
54. Gayoso CW, Lima EO, Oliveira VT, Pereira FO, Souza EL, Lima IO, et al. Sensitivity of fungi isolated from onychomycosis to Eugenia caryophyllata essential oil and eugenol. J Fitoterapia 2005;76:247-9.
55. Ahmad N, Alam MK, Shehbaz A, Khan A, Mannan A, Rashid Hakim S, Bisht D, Owais M. Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis. J Drug Target 2005;13:555-61.
56. Manohar V, Ingram C, Gray J, Talpur N A, Echard B W, Bagchi D, Preuss H G. Antifungal activities of origanum oil against Candida albicans. J Mol Cell Biochem 2001;228:111-7.
57. Rana IS, Rana AS, Rajak RC. Evaluation of antifungal activity in essential oil of the Syzygium aromaticum (L.) by extraction, purification and analysis of its main component eugenol. Braz J Microbiol 2011;42(4):1269-77.
58. Devi KP, Nisha SA, Sakthivel R, Pandian SK. Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane. J Ethnopharmacol 2010;130(1):107-15.
59. Dorman HJD, Figueiredo AC, Barroso JG, Deans SG. In vitro evaluation of antioxidant activity of essential oils and their components. Flav Frag J 2000;15:12-6.
60. Gulcin I, Elmastas M, Hassan Y, Enein A. Antioxidant activity of clove oil – A powerful antioxidant source. Arabian J Chem 2012;5:489-99.
61. Abozid MM, Sayed EL. Antioxidant and protective effect of clove extracts and clove essential oil on hydrogen peroxide treated rats. Int J Chem Tech Res 2013;5(4):1477-85.
62. Calleja MA, Vieites JM, Montero-Meléndez T, Torres MI, Faus MJ, Suárez A. The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. Br J Nutr 2014;109(3):394-401.
63. Miyazawa M, Hisama M. Suppression of chemical mutagen induced SOS response by alkylphenols from clove (Syzygium aromaticum) in Salmonella typhymurium TA153/pSK1002 umu test. J Agric Food Chem 2001;49:4019-25.
64. Schonfelder I, Schonfelder P. Syzygium aromaticum (L.) MERR & PERR (Eugenia caryophyllata THUNB Jambosa caryophyllus (SPRENG.) (NIEDENZU). J Das neue Handbuch der Heilpflanzen, Kosmos‐Verlag, Stuttgart, Germany 2004;431‐2.
65. Liu H, Schmitz JC, Wei J, Cao S, Beumer JH, Strychor S, et al. Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis. J Oncol Res 2014;21(5):247-59.
66. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 2005;280(7):5812-9.
67. Hussain A, Brahmbhatt K, Priyani A, et al. Eugenol enhances the chemotherapeutic potential of gemcitabine and induce anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. J Cancer Biother Radiopharm 2011;26(5):519-27.
68. Hosseini M, Asl MK, Rakhshandeh H, Analgesic effect of clove essential oil in mice. Avicenna J Phytomed 2011;1(1):1-6.
69. Raghavenra H, Diwakr BT, Lokesh BR, Naidu KA. Eugenol-The active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells. J Prostaglandins Leukot Essent Fatty Acids 2006;74:23-7.
70. Kozam G. The effect of eugenol on nerve transmission. J Oral Surg Oral Med Oral Pathol 1977;44:799-805.
71. Aoshima H, Hamamoto K. Potentiation of GABA A receptors expressed in Xenopus oocytes by perfume and phytoncid. J Biosci Biotechnol Biochem 1999;63:743-8.
72. Ozturk A, Ozbek H. The anti-Inflammatory activity of Eugenia caryophyllata essential Oil. An animal model of anti-inflammatory activity. Eur J Gen Med 2005;2(4):159-63.
73. Kim EH, Kim HK, Ahn YJ. Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari:Pyroglyphidae). J Agric Food Chem 2003;51(4):885-9.
74. Daniel AN, Sartoretto SM, Schmidt G, Caparroz-Assef SM, Bersani-Amado CA, Cuman RKN. Anti-inflammatory and antinociceptive activities of eugenol essential oil in experimental animal models. J Rev Bras Farmacogn 2009;19:212-7.
75. Saeed SA, Gilani AH. Antithrombotic activity of clove oil. J Pak Med Assoc 1994;44(5):112-5.
76. Rasheed A, Laekeman G, Totte J, Vlietinck A J, Herman A G. Eugenol and prostaglandin biosynthesis. N Engl J Med 1984;310:50-1.
77. Srivastava KC. Antiplatelet principles from a food spice clove (Syzygium aromaticum L). J Prostaglandins Leukot Essent Fatty Acids 1993;48:363-72.
78. Taylor PW, Roberts SD. Clove oil:An alternative anesthetic for aquaculture. N Am J Aquacult 1999;61:150-5.
79. Ross LG, Ross B. Anaesthetic and Sedative Techniques for Aquatic Animals. 3rd Edition. Blackwell Oxford. 2008;ISBN-978-1-4051-4938-9.
80. Pongprayoon U, Baekstorm P, Jacobsso U, Linstorm M, Bohlin L. Compounds inhibiting prostaglandin synthesis isolated from Ipomoea pes-caprae. J Planta Med 1991;57:515-18.
81. Hamackova J, Kouril J, Kozak P, Stupka Z. Clove Oil as an anaesthetic for different freshwater fish species. Bulg J Agric Sci 2006;12:185-94.
82. Grush. The Efficacy of Clove Oil As An Anesthetic for the Zebrafish, Danio rerio (Hamilton). J Zebrafish 2004;1(1).
83. Lima FC, Peixoto-Neves D, Gomes MD, Coelho-de-Souza AN, Lima CC, Araujo Zin W, et al. Antispasmodic effects of eugenol on rat airway smooth muscle. J Fundam Clin Pharmacol 2011;25(6):690-9.
84. Feng J, Lipton JM. Eugenol:Antipyretic activity in rabbits. J Neuropharmacol 1987;26:1775-8.
85. Tao G, Irie Y, Li DJ, Keung WM. Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity. J Bioorgan Med Chem 2005;13:4777-88.
86. Obeng Ofori D, Reichmuth C. Bioactivity of eugenol, a major component of essential oil of Ocimum suave (Wild.) against four species of stored-product Coleoptera. Int J Pest Manag 1997;43:89–94.
2179 Views | 2682 Downloads
How to Cite
Mittal, M., N. Gupta, P. Parashar, V. Mehra, and M. Khatri. “PHYTOCHEMICAL EVALUATION AND PHARMACOLOGICAL ACTIVITY OF SYZYGIUM AROMATICUM: A COMPREHENSIVE REVIEW”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 6, no. 8, Sept. 2014, pp. 67-72,
Review Article(s)